High frequency of asymptomatic Leishmania spp. infection among HIV-infected patients living in endemic areas for visceral leishmaniasis in Brazil

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 106, Issue 5, 2012, Pages 283-288

  Orsini, Marcela ^a,b   Canela, João R ^c   Disch, J ^a   Maciel, F ^a   Greco, Dirceu ^b   Toledo, Antonio ^d   Rabello, Ana ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIMONTES   (Brazil)

^d Universidade Jose do Rosario Vellano   (Brazil)

Author keywords

AIDS; Brazil; HIV; Leishmania infantum; Leishmaniasis; Visceral leishmaniasis

Indexed keywords

ADULT; ARTICLE; ASYMPTOMATIC INFECTION; BRAZIL; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDY; ENDEMIC DISEASE; FEMALE; HEPATOSPLENOMEGALY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LEISHMANIA; LEISHMANIA INFANTUM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; VIRUS LOAD; VISCERAL LEISHMANIASIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BRAZIL; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; DNA, KINETOPLAST; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HIV SEROPOSITIVITY; HIV-1; HUMANS; LEISHMANIA; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; YOUNG ADULT;

LEISHMANIA INFANTUM;

EID: 84859837098     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2012.01.008     Document Type: Article

References (32)

1. Cruz I., Nieto J., Moreno J., Canavate C., Desjeux P., Alvar J. Leishmania/HIV co-infections in the second decade. Indian J Med Res 2006, 123:357-388.
2. Brazil. Ministry of Health. Department of Health Surveillance. AIDS incidence in Brazil [in Portuguese]. STD/AIDS Epidemiol Bull 2010;8:3.
3. Brazil. Ministry of Health. Department of Health Surveillance. Leishmaniosis history and epidemiological trends and current situation. In: Brazil. Ministry of Health, editor. Recommendations for diagnosis, treatment and follow-up of patients with HIV-Leismania co-infection [in Portuguese]. Brasilia: Brazil. Ministry of Health; 2011. p. 7-13.
4. Alonso M.J., Munoz E., Picazo A., et al. Duodenal leishmaniasis diagnosed by biopsy in two HIV-positive patients. Pathol Res Pract 1997, 193:43-47. discussion 9-50.
5. Cascio A., Gradoni L., Scarlata F., et al. Epidemiologic surveillance of visceral leishmaniasis in Sicily, Italy. Am J Trop Med Hyg 1997, 57:75-78.
6. Colebunders R., Depraetere K., Verstraeten T., et al. Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection. J Am Acad Dermatol 1999, 41:847-850.
7. Alvar J., Canavate C., Gutierrez-Solar B., et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 1997, 10:298-319.
8. Costa C.H., Stewart J.M., Gomes R.B., et al. Asymptomatic human carriers of Leishmania chagasi. Am J Trop Med Hyg 2002, 66:334-337.
9. Cruz I., Canavate C., Rubio J.M., et al. A nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus. Trans R Soc Trop Med Hyg 2002, 96:S185-S189.
10. Degrave W., Fernandes O., Campbell D., Bozza M., Lopes U. Use of molecular probes and PCR for detection and typing of Leishmania--a mini-review. Mem Inst Oswaldo Cruz 1994, 89:463-469.
11. Cupolillo E., Grimaldi Junior G., Momen H., Beverley S.M. Intergenic region typing (IRT): a rapid molecular approach to the characterization and evolution of Leishmania. Mol Biochem Parasitol 1995, 73:145-155.
12. Garcia-Garcia J.A., Martin-Sanchez J., Gallego M., et al. Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients. J Clin Microbiol 2006, 44:4455-4458.
13. Ozkan A.T., Yalcinkaya T., Kilic S., Babur C., Schallig H.D. Investigation of Leishmania infantum seropositivity in HIV/AIDS patients. Mikrobiyol Bul 2008, 42:113-117.
14. Pineda J.A., Gallardo J.A., Macias J., et al. Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain. J Clin Microbiol 1998, 36:2419-2422.
15. Garrote J.I., Gutierrez M.P., Izquierdo R.L., et al. Seroepidemiologic study of Leishmania infantum infection in Castilla-Leon, Spain. Am J Trop Med Hyg 2004, 71:403-406.
16. Carranza-Tamayo C.O., de Assis T.S., Neri A.T., Cupolillo E., Rabello A., Romero G.A. Prevalence of Leishmania infection in adult HIV/AIDS patients treated in a tertiary-level care center in Brasilia, Federal District, Brazil. Trans R Soc Trop Med Hyg 2009, 103:743-748.
17. Pedras M.J., de Gouvêa Viana L., de Oliveira E.J., Rabello A. Comparative evaluation of direct agglutination test, rK39 and soluble antigen ELISA and IFAT for the diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg 2008, 102:172-178.
18. Disch J., Caligiorne R.B., Maciel F., et al. Single-step duplex kDNA-PCR for detection of Leishmania donovani complex in human peripheral blood samples. Diagn Microbiol Infect Dis 2006, 56:395-400.
19. Disch J., Maciel F.C., de Oliveira M.C., Orsini M., Rabello A. Detection of circulating Leishmania chagasi DNA for the non-invasive diagnosis of human infection. Trans R Soc Trop Med Hyg 2003, 97:391-395.
20. Brazil. Ministry of Health. Department of Health Surveillance. Manual of visceral leishmaniosis surveillance and control [in Portuguese]. Brasília: Brazil. Ministry of Health; 2004.
21. Silveira F.T., Lainson R., Pereira E.A., et al. A longitudinal study on the transmission dynamics of human Leishmania (Leishmania) infantum chagasi infection in Amazonian Brazil, with special reference to its prevalence and incidence. Parasitol Res 2009, 104:559-567.
22. Moreno E.C., Melo M.N., Lambertucci J.R., et al. Diagnosing human asymptomatic visceral leishmaniasis in an urban area of the State of Minas Gerais, using serological and molecular biology techniques. Rev Soc Bras Med Trop 2006, 39:421-427.
23. Badaro R., Jones T.C., Carvalho E.M., et al. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 1986, 154:1003-1011.
24. Pearson R.D., Sousa A.Q. Clinical spectrum of Leishmaniasis. Clin Infect Dis 1996, 22:1-13.
25. Singh S., Kumari V., Singh N. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen. Clin Diagn Lab Immunol 2002, 9:568-572.
26. de La Rosa R., Pineda J.A., Delgado J., et al. Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy. J Clin Microbiol 2002, 40:762-767.
27. Tumbarello M., Tacconelli E., Bertagnolio S., Cauda R. Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals. AIDS 2000, 14:2948-2949.
28. Rosenthal E., Tempesta S., Del Giudice P., et al. Declining incidence of visceral leishmaniasis in HIV-infected individuals in the era of highly active antiretroviral therapy. AIDS 2001, 15:1184-1185.
29. Soriano V., Dona C., Rodriguez-Rosado R., Barreiro P., Gonzalez-Lahoz J. Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy. AIDS 2000, 14:383-386.
30. Schaefer K.U., Schoone G.J., Gachihi G.S., Muller A.S., Kager P.A., Meredith S.E. Visceral leishmaniasis: use of the polymerase chain reaction in an epidemiological study in Baringo District, Kenya. Trans R Soc Trop Med Hyg 1995, 89:492-495.
31. de Gouvea Viana L., de Assis T.S., Orsini M., et al. Combined diagnostic methods identify a remarkable proportion of asymptomatic Leishmania (Leishmania) chagasi carriers who present modulated cytokine profiles. Trans R Soc Trop Med Hyg 2008, 102:548-555.
32. Medrano F.J., Canavate C., Leal M., Rey C., Lissen E., Alvar J. The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1. Am J Trop Med Hyg 1998, 59:155-162.